Results 241 to 250 of about 37,893 (278)
Some of the next articles are maybe not open access.

Lymphomas and Oncolytic Virus Therapy

Clinical Lymphoma, 2003
There are several well-documented cases in medical literature of the remission of leukemias and malignant lymphomas following natural human viral infections. In the hope of being able to reproduce these spontaneous tumor regressions, investigators have studied various viruses with distinct oncolytic properties. The first attempts to treat patients with
Tommy, Alain   +6 more
openaire   +2 more sources

Virus, Oncolytic Virus and Human Prostate Cancer

Current Cancer Drug Targets, 2017
Prostate cancer (PCa), a disease, is characterized by abnormal cell growth in the prostate - a gland in the male reproductive system. Although older age and a family history of the disease have been recognized as the risk factors of PCa, the cause of this cancer remains unclear.
Liu, Guang Bin   +3 more
openaire   +3 more sources

Oscillations in a Spatial Oncolytic Virus Model

Bulletin of Mathematical Biology, 2023
AbstractVirotherapy treatment is a new and promising target therapy that selectively attacks cancer cells without harming normal cells. Mathematical models of oncolytic viruses have shown predator-prey like oscillatory patterns as result of an underlying Hopf bifurcation.
Arwa Abdulla Baabdulla, Thomas Hillen
openaire   +3 more sources

Regulatory Aspects of Oncolytic Virus Products

Current Cancer Drug Targets, 2007
Many types of oncolytic viruses, wild-type virus, attenuated viruses and genetically-modified viruses, have been developed as an innovative cancer therapy. The strategies, nature, and technologies of oncolytic virus products are different from the conventional gene therapy products or cancer therapy products.
Teruhide, Yamaguchi, Eriko, Uchida
openaire   +2 more sources

Oncolytic Herpes Virus Shrinks Pediatric Gliomas

Cancer Discovery, 2021
Abstract In a small trial involving children with progressive high-grade gliomas, direct infusions of a genetically engineered strain of herpes simplex virus elicited responses in 11 of 12 recipients. The therapy also led to more than a doubling in average patient survival compared with historical expectations.
openaire   +2 more sources

Progress of Oncolytic Virus

Journal of Biomedical Nanotechnology
Oncolytic viruses have made tremendous advances in fundamental research and clinical trials in recent years as potential anti-cancer medications. Oncolytic viruses, which are either genetically modified or naturally occurring, can kill cancer cells without harming healthy cells.
Chen Wu   +3 more
openaire   +1 more source

Oncolytic virus therapy for prostate cancer

International Journal of Urology, 2009
AbstractThe use of replication‐competent viruses that can selectively replicate in and destroy neoplastic cells is an attractive strategy for treating cancer. Various oncolytic viruses have been taken to clinical trials since a recombinant virus was first applied to cancer patients a decade ago.
Hiroshi, Fukuhara   +2 more
openaire   +2 more sources

Spatial Oncolytic Virus Dynamics

2013
Tumors are often characterized by intricate spatial structures. Therefore, understanding the principles of virus spread in spatially structured tumor cell populations is of fundamental importance. This chapter describes a two-dimensional spatial model where cells and viruses can place their offspring only into the direct vicinity. This describes a cell
Natalia L. Komarova, Dominik Wodarz
openaire   +1 more source

Measles as a potential oncolytic virus

Reviews in Medical Virology, 2005
The use of replicating viruses for cancer therapy is attracting increasing interest. Numerous viruses are now being considered as potential cancer therapeutics, including the vaccine strain of measles virus (MV). The attenuated strain of measles readily lyses transformed cells, whilst replication and lysis are limited in normal human cells.
openaire   +2 more sources

Cancer gene and oncolytic virus therapy

Seminars in Oncology, 2001
By far, cancer accounts for the majority of gene therapy trials that are being carried out worldwide. Seventy percent of the gene therapy protocols that have been reviewed by the National Institutes of Health Recombinant DNA Advisory Committee (NIH RAC) are for the treatment of cancer.
openaire   +2 more sources

Home - About - Disclaimer - Privacy